Autopsy report · NCT05839600
A Study to Find a Suitable Dose of BI 1821736 and Test Whether it Helps People With Advanced Cancer
Cause of deathNo reason given
Life of this trial
- Registered 2 months before it started.
- Ran for about 1 year 10 months before it stopped.
- 10 participants enrolled.
- Results were posted on the registry 1 year 1 month after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 1
- Sponsor
- Boehringer Ingelheim
- Sponsor type
- Industry
- Conditions
- Solid Tumors
- Interventions
- BI 1821736
- Participants
- 10
- Sites
- 8
- Countries
- Canada, Spain, Sweden, United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.